Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05974150 · ClinicalTrials.gov registry record
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
A clinical trial of Breast Cancer and Multiple Myeloma, sponsored by Carevive Systems.
- Recruiting
- Registry status
- 25
- Enrollment target
- 7
- Study locations
NCT05974150: Recruiting study of Breast Cancer and Multiple Myeloma, sponsored by Carevive Systems.
NCT05974150 is a study of Breast Cancer and Multiple Myeloma that is actively recruiting participants, run by Carevive Systems. The registered enrollment target is 25 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 7 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05974150, a study of Breast Cancer and Multiple Myeloma, is actively recruiting participants, sponsored by Carevive Systems.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 7
- Study locations
Study Summary
The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system (CPS) with remote symptom monitoring that is used in routine care for cancer patients on active treatment. Patients will complete a baseline survey in person using a secured device or remotely using their own electronic device in a location of their choice. Weekly electronic patient reported outcome (PRO) surveys are collected from the patients using the Carevive platform for a minimum of 12 weeks. Patients may continue weekly surveys as long as they are receiving treatment.
Primary Outcome
The goal of this registry is to create a data set from real world clinical and patient reported data collected using an electronic care planning system (CPS) that is used in routine care for cancer patients on active treatment
Conditions Studied
Interventions
- OTHER Web based survey
Study Locations (7)
Ohio
- Cleveland Clinic Mercy Hospital - Canton
- University Hospitals Seidman Cancer Center - Cleveland
- Tri-County Hematology & Oncology Associates, Inc. - Massillon
North Carolina
- Univeristy of North Carolina at Chapel Hill - Chapel Hill
- Duke - Durham
Connecticut
- Yale Cancer Center - New Haven
Illinois
- Northshore University Health System - Evanston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-07-19 |
| Est. Completion | 2026-12-31 |
What NCT05974150 shows while recruiting
NCT05974150 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower).
The record links to 5 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Web based survey is the first listed.
NCT05974150 lists 7 locations in 4 states (Ohio, North Carolina, Connecticut).
Frequently Asked Questions
What is clinical trial NCT05974150 about?
NCT05974150 is a clinical study titled "Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring". The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system (CPS) with remote symptom monitoring that is used in routine care for cancer patients on active treatment. Patients will...
What is the current status of trial NCT05974150?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2023-07-19. Estimated completion is 2026-12-31.
What conditions does trial NCT05974150 study?
This clinical trial studies the following conditions: Breast Cancer, Multiple Myeloma, Lung Cancer, Ovarian Cancer, Acute Myelogenous Leukemia.
What interventions are being tested in trial NCT05974150?
The interventions under investigation include: Web based survey (OTHER).
Who is sponsoring clinical trial NCT05974150?
This trial is sponsored by Carevive Systems, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05974150 being conducted?
This trial has 7 study locations across Connecticut, Illinois, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05974150's enrollment target sits among peer trials
25 1031st of 1224 higher than 184 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI